Endocrine therapy in breast cancer treatment
- Submitting institution
-
Institute of Cancer Research: Royal Cancer Hospital (The)
- Unit of assessment
- 1 - Clinical Medicine
- Summary impact type
- Health
- Request cross-referral to
- -
- Is this case study continued from a case study submitted in 2014?
- No
- Underpinning research subjects
-
- Clinical Sciences
- Oncology And Carcinogenesis
- Public Health And Health Services
3. References to the research
5. Sources to corroborate the impact
Additional contextual information
Grant funding
Grant number |
Value of grant |
BBC024X (internal) |
£30,872,915 |
None given (BRC 2007) |
£46,800,000 |
CTR-Q3-Y2 |
£23,200,000 |
C569/10404 |
£0 |
CTR-Q4 |
£39,327,814 |
C569/A16891 |
£0 |
KG080081 |
£0 |
BRC-2011-10059 |
£61,543,735 |
IS-BRC-1215-20021 |
£43,074,315 |
- Countries
-
- US
- UK
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czechia
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Latvia
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
- Iceland
- Liechtenstein
- Norway
- Switzerland
- Canada
- Israel
- Australia
- China
- New Zealand
- Formal partners
-
- The Royal Marsden NHS Foundation Trust
- Queen Mary University of London
- University College London
- Pfizer
- Funding programmes
-
- Breast Cancer Now (previously Breakthrough Breast Cancer) Centre Core Grant 2003 to 2010
- The National Institute for Health Research Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (2007)
- Breast Cancer Now (previously Breakthrough Breast Cancer) Centre Core Grant 2011 to 2015
- Cancer Research UK grant C569/10404
- Breast Cancer Now (previously Breakthrough Breast Cancer) Centre Core Grant 2015 to 2021
- Cancer Research UK grant C569/A16891
- Susan G. Komen: Cure Promise Grant
- The National Institute for Health Research Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (2012)
- The National Institute for Health Research Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (2017)
- Global research identifiers
-
- grid.458394.7
- grid.451056.3
- grid.11485.39
- grid.428834.1
- Name of funders
-
- Breakthrough Breast Cancer (now Breast Cancer Now)
- National Institute for Health Research
- Cancer Research UK
- Susan G. Komen
- Researcher ORCIDs
-
- 0000-0003-4122-744X
- 0000-0001-8937-0873
- 0000-0001-7957-7424
- 0000-0001-5718-2501
- 0000-0002-9072-2749